OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,129,000 | +41.3% | 288,780 | -16.5% | 0.00% | +50.0% |
Q4 2020 | $799,000 | -56.5% | 345,706 | +7.9% | 0.00% | -71.4% |
Q3 2020 | $1,838,000 | +1897.8% | 320,265 | +932.7% | 0.01% | +600.0% |
Q1 2020 | $92,000 | -86.9% | 31,012 | -81.6% | 0.00% | -50.0% |
Q4 2019 | $700,000 | +3584.2% | 168,602 | +1528.7% | 0.00% | – |
Q2 2019 | $19,000 | -74.7% | 10,352 | -75.6% | 0.00% | – |
Q1 2019 | $75,000 | -34.2% | 42,360 | -10.4% | 0.00% | – |
Q4 2018 | $114,000 | – | 47,263 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
XTX Topco Ltd | 50,569 | $198,000 | 0.07% |